Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionDNA-binding transcription factor activity, RNA polymerase II-specific

ZNF133 ZNF444 ZNF140 ZNF672 ZNF154 ZNF696 ZNF225 ZNF829 PRDM2 ZNF836 WIZ ZNF358 ZNF644 SPDEF ONECUT3 ZNF345 NPAS1 ZNF311 ZNF573 ZNF607 IRF8 E4F1 ZNF101 ZNF251 ZNF768 ZBTB46 ZNF517 ZNF540 ZSCAN5C ZNF749 ZFP92 ZSCAN16 ZNF565 ZNF324B ZNF333 ZNF700 ST18 ZNF646

1.90e-08141220038GO:0000981
GeneOntologyMolecularFunctionRNA polymerase II transcription regulatory region sequence-specific DNA binding

ZNF133 ZNF444 ZNF140 ZNF672 ZNF154 ZNF696 ZNF225 ZNF829 PRDM2 ZNF836 WIZ SARS1 ZNF358 ZNF644 ONECUT3 ZNF345 NPAS1 ZNF311 ZNF573 ZNF607 IRF8 E4F1 ZNF101 ZNF251 ZNF768 ZNF517 ZNF540 ZSCAN5C ZNF749 ZFP92 ZSCAN16 ZNF565 ZNF324B ZNF333 ZNF700 ST18 ZNF646

1.38e-07145920037GO:0000977
GeneOntologyMolecularFunctionRNA polymerase II cis-regulatory region sequence-specific DNA binding

ZNF444 ZNF140 ZNF154 ZNF225 ZNF829 ZNF836 WIZ SARS1 ZNF358 ZNF644 ONECUT3 ZNF345 ZNF311 ZNF573 ZNF607 IRF8 E4F1 ZNF101 ZNF251 ZNF768 ZNF540 ZSCAN5C ZFP92 ZSCAN16 ZNF565 ZNF324B ZNF333 ST18 ZNF646

1.86e-05124420029GO:0000978
GeneOntologyMolecularFunctioncis-regulatory region sequence-specific DNA binding

ZNF444 ZNF140 ZNF154 ZNF225 ZNF829 ZNF836 WIZ SARS1 ZNF358 ZNF644 ONECUT3 ZNF345 ZNF311 ZNF573 ZNF607 IRF8 E4F1 ZNF101 ZNF251 ZNF768 ZNF540 ZSCAN5C ZFP92 ZSCAN16 ZNF565 ZNF324B ZNF333 ST18 ZNF646

2.77e-05127120029GO:0000987
GeneOntologyMolecularFunctionoxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor

GLUD1 GLUD2

9.98e-0522002GO:0016639
GeneOntologyMolecularFunctionglutamate dehydrogenase [NAD(P)+] activity

GLUD1 GLUD2

9.98e-0522002GO:0004353
GeneOntologyMolecularFunctionglutamate dehydrogenase (NAD+) activity

GLUD1 GLUD2

9.98e-0522002GO:0004352
GeneOntologyMolecularFunctionglutamate dehydrogenase (NADP+) activity

GLUD1 GLUD2

9.98e-0522002GO:0004354
DomainZnf_C2H2/integrase_DNA-bd

ZNF133 ZNF444 ZNF140 ZNF672 ZNF154 ZNF696 ZNF225 ZNF829 PRDM2 ZNF836 ZNF358 ZNF644 AEBP2 ZNF345 ZNF311 ZNF573 ZNF607 E4F1 ZNF101 ZNF251 ZNF768 ZBTB46 ZNF517 ZNF540 ZSCAN5C ZNF749 ZFP92 ZSCAN16 ZNF565 ZNF324B ZNF333 ZNF700 ZNF646

3.98e-1369419833IPR013087
Domain-

ZNF133 ZNF444 ZNF140 ZNF672 ZNF154 ZNF696 ZNF225 ZNF829 PRDM2 ZNF836 ZNF358 ZNF644 AEBP2 ZNF345 ZNF311 ZNF573 ZNF607 E4F1 ZNF101 ZNF251 ZNF768 ZBTB46 ZNF517 ZNF540 ZNF749 ZFP92 ZSCAN16 ZNF565 ZNF324B ZNF333 ZNF700 ZNF646

1.20e-12679198323.30.160.60
DomainZINC_FINGER_C2H2_2

ZNF133 ZNF444 ZNF140 ZNF672 ZNF154 ZNF696 ZNF225 ZNF829 PRDM2 ZNF836 WIZ ZNF358 ZNF644 AEBP2 ZNF345 ZNF311 ZNF573 ZNF607 E4F1 ZNF101 ZNF251 ZNF768 ZBTB46 ZNF517 ZNF540 ZSCAN5C ZNF749 ZFP92 ZSCAN16 ZNF565 ZNF324B ZNF333 ZNF700 ZNF646

1.61e-1277519834PS50157
DomainZINC_FINGER_C2H2_1

ZNF133 ZNF444 ZNF140 ZNF672 ZNF154 ZNF696 ZNF225 ZNF829 PRDM2 ZNF836 WIZ ZNF358 ZNF644 AEBP2 ZNF345 ZNF311 ZNF573 ZNF607 E4F1 ZNF101 ZNF251 ZNF768 ZBTB46 ZNF517 ZNF540 ZSCAN5C ZNF749 ZFP92 ZSCAN16 ZNF565 ZNF324B ZNF333 ZNF700 ZNF646

1.73e-1277719834PS00028
Domainzf-C2H2

ZNF133 ZNF444 ZNF140 ZNF672 ZNF154 ZNF696 ZNF225 ZNF829 PRDM2 ZNF836 ZNF358 ZNF644 ZNF345 ZNF311 ZNF573 ZNF607 E4F1 ZNF101 ZNF251 ZNF768 ZBTB46 ZNF517 ZNF540 ZSCAN5C ZNF749 ZFP92 ZSCAN16 ZNF565 ZNF324B ZNF333 ZNF700 ZNF646

2.06e-1269319832PF00096
DomainZnf_C2H2-like

ZNF133 ZNF444 ZNF140 ZNF672 ZNF154 ZNF696 ZNF225 ZNF829 PRDM2 ZNF836 WIZ ZNF358 ZNF644 AEBP2 ZNF345 ZNF311 ZNF573 ZNF607 E4F1 ZNF101 ZNF251 ZNF768 ZBTB46 ZNF517 ZNF540 ZSCAN5C ZNF749 ZFP92 ZSCAN16 ZNF565 ZNF324B ZNF333 ZNF700 ZNF646

3.39e-1279619834IPR015880
DomainZnf_C2H2

ZNF133 ZNF444 ZNF140 ZNF672 ZNF154 ZNF696 ZNF225 ZNF829 PRDM2 ZNF836 WIZ ZNF358 ZNF644 AEBP2 ZNF345 ZNF311 ZNF573 ZNF607 E4F1 ZNF101 ZNF251 ZNF768 ZBTB46 ZNF517 ZNF540 ZSCAN5C ZNF749 ZFP92 ZSCAN16 ZNF565 ZNF324B ZNF333 ZNF700 ZNF646

4.63e-1280519834IPR007087
DomainZnF_C2H2

ZNF133 ZNF444 ZNF140 ZNF672 ZNF154 ZNF696 ZNF225 ZNF829 PRDM2 ZNF836 WIZ ZNF358 ZNF644 AEBP2 ZNF345 ZNF311 ZNF573 ZNF607 E4F1 ZNF101 ZNF251 ZNF768 ZBTB46 ZNF517 ZNF540 ZSCAN5C ZNF749 ZFP92 ZSCAN16 ZNF565 ZNF324B ZNF333 ZNF700 ZNF646

5.12e-1280819834SM00355
Domainzf-C2H2_6

ZNF133 ZNF140 ZNF672 ZNF154 ZNF225 PRDM2 ZNF836 ZNF358 ZNF345 ZNF311 ZNF573 ZNF607 E4F1 ZNF251 ZNF540 ZNF749 ZFP92 ZNF324B ZNF333 ZNF700 ZNF646

2.12e-1131419821PF13912
DomainKRAB

ZNF133 ZNF140 ZNF154 ZNF225 ZNF829 ZNF836 ZNF311 ZNF573 ZNF607 ZNF101 ZNF251 ZNF517 ZNF540 ZNF749 ZFP92 ZNF565 ZNF324B ZNF333 ZNF700

9.38e-0935819819PS50805
DomainKRAB

ZNF133 ZNF140 ZNF154 ZNF225 ZNF829 ZNF836 ZNF311 ZNF573 ZNF607 ZNF101 ZNF251 ZNF517 ZNF540 ZNF749 ZFP92 ZNF565 ZNF324B ZNF333 ZNF700

9.38e-0935819819PF01352
DomainKRAB

ZNF133 ZNF140 ZNF154 ZNF225 ZNF829 ZNF836 ZNF311 ZNF573 ZNF607 ZNF101 ZNF251 ZNF517 ZNF540 ZNF749 ZFP92 ZNF565 ZNF324B ZNF333 ZNF700

1.53e-0836919819SM00349
DomainKRAB

ZNF133 ZNF140 ZNF154 ZNF225 ZNF829 ZNF836 ZNF311 ZNF573 ZNF607 ZNF101 ZNF251 ZNF517 ZNF540 ZNF749 ZFP92 ZNF565 ZNF324B ZNF333 ZNF700

1.60e-0837019819IPR001909
DomainELFV_dehydrog_N

GLUD1 GLUD2

1.12e-0421982PF02812
DomainGlu/Leu/Phe/Val_DH_C

GLUD1 GLUD2

1.12e-0421982IPR006096
DomainGlu/Leu/Phe/Val_DH_dimer_dom

GLUD1 GLUD2

1.12e-0421982IPR006097
DomainGlu/Leu/Phe/Val_DH

GLUD1 GLUD2

1.12e-0421982IPR006095
DomainELFV_dehydrog

GLUD1 GLUD2

1.12e-0421982PF00208
DomainNAD_bind_Glu_DH

GLUD1 GLUD2

1.12e-0421982IPR033922
DomainGLFV_DEHYDROGENASE

GLUD1 GLUD2

1.12e-0421982PS00074
DomainA1A_glycop

ORM1 ORM2

1.12e-0421982IPR001500
DomainELFV_dehydrog

GLUD1 GLUD2

1.12e-0421982SM00839
DomainGlu/Leu/Phe/Val_DH_AS

GLUD1 GLUD2

1.12e-0421982IPR033524
DomainGFP-like

EGFL6 HMCN1 SUSD1

1.82e-04111983IPR023413
Domain-

EGFL6 HMCN1 SUSD1

1.82e-041119832.40.155.10
Domain-

CHAF1B WDR46 CDC20B FBXW2 PLXND1 DDB1 MET SEMA4F LLGL2 CFAP52 WDR73 MAPKBP1

2.37e-04333198122.130.10.10
DomainWD40/YVTN_repeat-like_dom

CHAF1B WDR46 CDC20B FBXW2 PLXND1 DDB1 MET SEMA4F LLGL2 CFAP52 WDR73 MAPKBP1

2.50e-0433519812IPR015943
DomainEGF_CA

NPNT EGFL6 HMCN1 MEGF8 SUSD1 LRP2

3.06e-04861986PF07645
DomainPlexin_repeat

PLXND1 MET SEMA4F MEGF8

3.49e-04321984IPR002165
DomainPSI

PLXND1 MET SEMA4F MEGF8

3.49e-04321984PF01437
DomainEGF_Ca-bd_CS

NPNT EGFL6 HMCN1 MEGF8 SUSD1 LRP2

5.84e-04971986IPR018097
DomainMAM_1

PTPRM NPNT EGFL6

5.94e-04161983PS00740
DomainEGF_CA

NPNT EGFL6 HMCN1 MEGF8 SUSD1 LRP2

6.51e-04991986PS01187
DomainASX_HYDROXYL

NPNT EGFL6 HMCN1 MEGF8 SUSD1 LRP2

6.87e-041001986PS00010
DomainMAM

PTPRM NPNT EGFL6

7.15e-04171983SM00137
DomainMAM

PTPRM NPNT EGFL6

8.51e-04181983PF00629
DomainMAM_dom

PTPRM NPNT EGFL6

8.51e-04181983IPR000998
DomainMAM_2

PTPRM NPNT EGFL6

8.51e-04181983PS50060
DomainEGF-type_Asp/Asn_hydroxyl_site

NPNT EGFL6 HMCN1 MEGF8 SUSD1 LRP2

9.32e-041061986IPR000152
DomainPSI

PLXND1 MET SEMA4F MEGF8

1.19e-03441984IPR016201
DomainGrowth_fac_rcpt_

NPNT EGFL6 HMCN1 MEGF8 SUSD1 LRP2 PCSK4

1.39e-031561987IPR009030
DomainPSI

PLXND1 MET SEMA4F MEGF8

1.41e-03461984SM00423
Pubmed

BCAR1 promotes proliferation and cell growth in lung adenocarcinoma via upregulation of POLR2A.

GDPD1 CHAF1B RDH13 WIZ FAM83D CRYZL1 TLK2 NUDT16 ZNF768 CASK RAB3GAP1 SLC34A1 WDR73

1.28e-064192031333001583
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

MAN2A2 MFHAS1 PLXND1 ADCY7 CDR2L KMT2C BMP4 TLK1 WIZ AP3D1 SEMA4F AOC2 ZDHHC5 SRGAP2 MED13L LLGL2 MEGF8 ARHGEF4 ZNF324B MAPKBP1 ULK2

2.33e-0611052032135748872
Pubmed

ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold.

ABCF1 MFHAS1 DDB1 EFTUD2 ZNF836 SARS1 TLK2 ZNF311 COPG1 ZNF251 CSE1L ZNF540 ZNF749

2.87e-064512031336168627
Pubmed

Human Tousled like kinases are targeted by an ATM- and Chk1-dependent DNA damage checkpoint.

CHEK1 TLK1 TLK2

3.87e-066203312660173
Pubmed

BPA modulates the WDR5/TET2 complex to regulate ERβ expression in eutopic endometrium and drives the development of endometriosis.

ABCF1 GIPC2 ACAT1 PFKL INTS3 DDB1 KMT2C SARS1 TXNDC5 HEPHL1 COPG1 TRMT112 UBE2O CSE1L ARFGAP1 RBM34

4.97e-067112031633022573
Pubmed

The in vivo Interaction Landscape of Histones H3.1 and H3.3.

CHAF1B SMC1A DLGAP5 DDB1 PRDM2 WIZ ZNF644 CENPT RADX DDX55 UBE2O SLC4A1AP RBM34 KDM4B

1.53e-056082031436089195
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

ZNF133 ZNF444 PDE3B TTLL3 ADGRG1 ADGRV1 PFKL INTS3 FARP2 PLEKHH1 KMT2C TLK1 EXD3 PTPRG MMP16 BEST1 SRGAP2 ATP10A CASK ZBTB46 ARHGEF4 CSMD1 KDM4B

2.22e-0514892032328611215
Pubmed

Distal promoter regions are responsible for differential regulation of human orosomucoid-1 and -2 gene expression and acute phase responses.

ORM1 ORM2

3.39e-052203224389491
Pubmed

A new strategy for identification of N-glycosylated proteins and unambiguous assignment of their glycosylation sites using HILIC enrichment and partial deglycosylation.

ORM1 ORM2

3.39e-052203215253437
Pubmed

Selective binding of coumarin enantiomers to human alpha1-acid glycoprotein genetic variants.

ORM1 ORM2

3.39e-052203216290938
Pubmed

Glutamate Delta-1 Receptor Regulates Inhibitory Neurotransmission in the Nucleus Accumbens Core and Anxiety-Like Behaviors.

GLUD1 GLUD2

3.39e-052203234173171
Pubmed

Glutamate dehydrogenase is essential to sustain neuronal oxidative energy metabolism during stimulation.

GLUD1 GLUD2

3.39e-052203228621566
Pubmed

Retinoids increase alpha-1 acid glycoprotein expression at the transcriptional level through two distinct DR1 retinoic acid responsive elements.

ORM1 ORM2

3.39e-052203215157739
Pubmed

GluD1 knockout mice with a pure C57BL/6N background show impaired fear memory, social interaction, and enhanced depressive-like behavior.

GLUD1 GLUD2

3.39e-052203232078638
Pubmed

Orosomucoid-1 Arises as a Shared Altered Protein in Two Models of Multiple Sclerosis.

ORM1 ORM2

3.39e-052203237949310
Pubmed

Gamma-COP appendage domain - structure and function.

COPG1 ARFGAP2

3.39e-052203214690497
Pubmed

Comparison of alpha-1-acid glycoprotein isoforms from healthy and cancer patients by capillary IEF.

ORM1 ORM2

3.39e-052203217987628
Pubmed

The expression of Tousled kinases in CaP cell lines and its relation to radiation response and DSB repair.

TLK1 TLK2

3.39e-052203221647934
Pubmed

α1-Acid Glycoprotein Enhances the Immunosuppressive and Protumor Functions of Tumor-Associated Macrophages.

ORM1 ORM2

3.39e-052203234210751
Pubmed

Development of mice with brain-specific deletion of floxed glud1 (glutamate dehydrogenase 1) using cre recombinase driven by the nestin promoter.

GLUD1 GLUD2

3.39e-052203223595828
Pubmed

Orosomucoid 1 promotes colorectal cancer progression and liver metastasis by affecting PI3K/AKT pathway and inducing macrophage M2 polarization.

ORM1 ORM2

3.39e-052203237640741
Pubmed

An acute phase protein α1-acid glycoprotein mitigates AKI and its progression to CKD through its anti-inflammatory action.

ORM1 ORM2

3.39e-052203233846468
Pubmed

Zbtb46 expression distinguishes classical dendritic cells and their committed progenitors from other immune lineages.

IRF8 ZBTB46

3.39e-052203222615127
Pubmed

Transcriptome Analysis Uncovers a Growth-Promoting Activity of Orosomucoid-1 on Hepatocytes.

ORM1 ORM2

3.39e-052203228927749
Pubmed

Interaction between glutamate dehydrogenase (GDH) and L-leucine catabolic enzymes: intersecting metabolic pathways.

GLUD1 GLUD2

3.39e-052203221621574
Pubmed

Identification of the molecular dysfunction caused by glutamate dehydrogenase S445L mutation responsible for hyperinsulinism/hyperammonemia.

GLUD1 GLUD2

3.39e-052203228911206
Pubmed

α1-Acid glycoprotein decreases neutrophil migration and increases susceptibility to sepsis in diabetic mice.

ORM1 ORM2

3.39e-052203222415874
Pubmed

Structure of 1 -acid glycoprotein. The complete amino acid sequence, multiple amino acid substitutions, and homology with the immunoglobulins.

ORM1 ORM2

3.39e-05220324711474
Pubmed

Structure and expression of the genes coding for human alpha 1-acid glycoprotein.

ORM1 ORM2

3.39e-05220322822385
Pubmed

Adipocytokine orosomucoid integrates inflammatory and metabolic signals to preserve energy homeostasis by resolving immoderate inflammation.

ORM1 ORM2

3.39e-052203220442402
Pubmed

Delineation of glutamate pathways and secretory responses in pancreatic islets with β-cell-specific abrogation of the glutamate dehydrogenase.

GLUD1 GLUD2

3.39e-052203222875990
Pubmed

Orosomucoid1: Involved in vascular endothelial growth factor-induced blood-brain barrier leakage after ischemic stroke in mouse.

ORM1 ORM2

3.39e-052203225264156
Pubmed

Molecular basis of human glutamate dehydrogenase regulation under changing energy demands.

GLUD1 GLUD2

3.39e-052203215578726
Pubmed

Important role of Ser443 in different thermal stability of human glutamate dehydrogenase isozymes.

GLUD1 GLUD2

3.39e-052203215044002
Pubmed

Tousled-Like Kinases Suppress Innate Immune Signaling Triggered by Alternative Lengthening of Telomeres.

TLK1 TLK2

3.39e-052203232755577
Pubmed

Molecular characterization and acute phase expression of the multiple Mus caroli alpha 1-acid glycoprotein (AGP) genes. Differences in glucocorticoid stimulation and regulatory elements between the rat and mouse AGP genes.

ORM1 ORM2

3.39e-05220322354997
Pubmed

Induction of excitatory and inhibitory presynaptic differentiation by GluD1.

GLUD1 GLUD2

3.39e-052203222138648
Pubmed

cDNA cloning and chromosomal mapping of genes encoding novel protein kinases termed PKU-alpha and PKU-beta, which have nuclear localization signal.

TLK1 TLK2

3.39e-05220329427565
Pubmed

Structural heterogeneity of glycoform of alpha-1 Acid glycoprotein in alcoholic cirrhosis patients.

ORM1 ORM2

3.39e-052203225408356
Pubmed

Glutamate Dehydrogenase Is Important for Ammonia Fixation and Amino Acid Homeostasis in Brain During Hyperammonemia.

GLUD1 GLUD2

3.39e-052203234220417
Pubmed

Nucleotide sequence of the mouse alpha 1-acid glycoprotein gene 1.

ORM1 ORM2

3.39e-05220323676251
Pubmed

Structure and characterisation of a duplicated human alpha 1 acid glycoprotein gene.

ORM1 ORM2

3.39e-05220322970990
Pubmed

Expression of human GLUD1 and GLUD2 glutamate dehydrogenases in steroid producing tissues.

GLUD1 GLUD2

3.39e-052203226241911
Pubmed

The disulfide bonds of alpha1-acid glycoprotein.

ORM1 ORM2

3.39e-05220324603214
Pubmed

Differential levels of glutamate dehydrogenase 1 (GLUD1) in Balb/c and C57BL/6 mice and the effects of overexpression of the Glud1 gene on glutamate release in striatum.

GLUD1 GLUD2

3.39e-052203221446915
Pubmed

Orm2 Deficiency Aggravates High-Fat Diet-Induced Obesity through Gut Microbial Dysbiosis and Intestinal Inflammation.

ORM1 ORM2

3.39e-052203237853937
Pubmed

GluD1 binds GABA and controls inhibitory plasticity.

GLUD1 GLUD2

3.39e-052203238060673
Pubmed

Gene expression patterns in the hippocampus during the development and aging of Glud1 (Glutamate Dehydrogenase 1) transgenic and wild type mice.

GLUD1 GLUD2

3.39e-052203224593767
Pubmed

Potentiation of neuronal activity by tonic GluD1 current in brain slices.

GLUD1 GLUD2

3.39e-052203237154294
Pubmed

A mouse gene family associated with a major submaxillary-gland glycoprotein.

ORM1 ORM2

3.39e-05220323977853
Pubmed

Deletion of glutamate dehydrogenase 1 (Glud1) in the central nervous system affects glutamate handling without altering synaptic transmission.

GLUD1 GLUD2

3.39e-052203222924626
Pubmed

Structure and expression of mouse alpha 1-acid glycoprotein gene-3 (AGP-3).

ORM1 ORM2

3.39e-05220321605854
Pubmed

Nerve tissue-specific (GLUD2) and housekeeping (GLUD1) human glutamate dehydrogenases are regulated by distinct allosteric mechanisms: implications for biologic function.

GLUD1 GLUD2

3.39e-052203211032875
Pubmed

Localization of Human Glutamate Dehydrogenases Provides Insights into Their Metabolic Role and Their Involvement in Disease Processes.

GLUD1 GLUD2

3.39e-052203229943084
Pubmed

High-resolution maps of the murine Chromosome 2 region containing the cholesterol gallstone locus, Lith1.

LRP2 ABCB11

3.39e-052203210556425
Pubmed

Glutamate dehydrogenase deficiency disrupts glutamate homeostasis in hippocampus and prefrontal cortex and impairs recognition memory.

GLUD1 GLUD2

3.39e-052203231898404
Pubmed

Birth and adaptive evolution of a hominoid gene that supports high neurotransmitter flux.

GLUD1 GLUD2

3.39e-052203215378063
Pubmed

Widening Spectrum of Cellular and Subcellular Expression of Human GLUD1 and GLUD2 Glutamate Dehydrogenases Suggests Novel Functions.

GLUD1 GLUD2

3.39e-052203227422263
Pubmed

Analysis of the five glycosylation sites of human alpha 1-acid glycoprotein.

ORM1 ORM2

3.39e-05220321567356
Pubmed

Plasma alpha-1-acid glycoprotein as a potential predictive biomarker for non-haematological adverse events of docetaxel in breast cancer patients.

ORM1 ORM2

3.39e-052203228554261
Pubmed

Genomic organization of profilin-III and evidence for a transcript expressed exclusively in testis.

PFN3 SLC34A1

3.39e-052203211867228
Pubmed

Critical role of the cysteine 323 residue in the catalytic activity of human glutamate dehydrogenase isozymes.

GLUD1 GLUD2

3.39e-052203215750346
Pubmed

Molecular cloning, structure and expression analysis of a full-length mouse brain glutamate dehydrogenase cDNA.

GLUD1 GLUD2

3.39e-05220321711373
Pubmed

Transcriptomic responses in mouse brain exposed to chronic excess of the neurotransmitter glutamate.

GLUD1 GLUD2

3.39e-052203220529287
Pubmed

Determination of glutamate dehydrogenase activity and its kinetics in mouse tissues using metabolic mapping (quantitative enzyme histochemistry).

GLUD1 GLUD2

3.39e-052203225124006
Pubmed

Unexpected histone H3 tail-clipping activity of glutamate dehydrogenase.

GLUD1 GLUD2

3.39e-052203223673664
Pubmed

Evidence for the existence of multiple alpha 1-acid glycoprotein genes in the mouse.

ORM1 ORM2

3.39e-05220323003086
Pubmed

Interaction of acute-phase-inducible and liver-enriched nuclear factors with the promoter region of the mouse alpha 1-acid glycoprotein gene-1.

ORM1 ORM2

3.39e-05220321371400
Pubmed

SILAC proteomics implicates SOCS1 in modulating cellular macromolecular complexes and the ubiquitin conjugating enzyme UBE2D involved in MET receptor tyrosine kinase downregulation.

MET SOCS1

3.39e-052203233493533
Pubmed

Lack of evidence for direct ligand-gated ion channel activity of GluD receptors.

GLUD1 GLUD2

3.39e-052203239052831
Pubmed

Structure of human alpha1-acid glycoprotein and its high-affinity binding site.

ORM1 ORM2

3.39e-052203212480518
Pubmed

Metabolism changes during aging in the hippocampus and striatum of glud1 (glutamate dehydrogenase 1) transgenic mice.

GLUD1 GLUD2

3.39e-052203224442550
Pubmed

The Amplifying Pathway of the β-Cell Contributes to Diet-induced Obesity.

GLUD1 GLUD2

3.39e-052203227137930
Pubmed

Orosomucoid in liver diseases.

ORM1 ORM2

3.39e-052203234963738
Pubmed

GDH-Dependent Glutamate Oxidation in the Brain Dictates Peripheral Energy Substrate Distribution.

GLUD1 GLUD2

3.39e-052203226440896
Pubmed

Genetic variations of orosomucoid genes associated with serum alpha-1-acid glycoprotein level and the pharmacokinetics of paclitaxel in Japanese cancer patients.

ORM1 ORM2

3.39e-052203221638284
Pubmed

Study of structure-function relationships in human glutamate dehydrogenases reveals novel molecular mechanisms for the regulation of the nerve tissue-specific (GLUD2) isoenzyme.

GLUD1 GLUD2

3.39e-052203212742085
Pubmed

Attenuation of MET-mediated migration and invasion in hepatocellular carcinoma cells by SOCS1.

MET SOCS1

3.39e-052203229085209
Pubmed

Regulation of MET receptor tyrosine kinase signaling by suppressor of cytokine signaling 1 in hepatocellular carcinoma.

MET SOCS1

3.39e-052203225728680
Pubmed

A protective role of IL-30 via STAT and ERK signaling pathways in macrophage-mediated inflammation.

SOCS1 IL27

3.39e-052203223583238
Pubmed

The bile acid induced hepatokine orosomucoid suppresses adipocyte differentiation.

ORM1 ORM2

3.39e-052203233168190
Pubmed

Mitigation of non-alcoholic steatohepatitis via recombinant Orosomucoid 2, an acute phase protein modulating the Erk1/2-PPARγ-Cd36 pathway.

ORM1 ORM2

3.39e-052203237355990
Pubmed

Molecular cloning of cDNAs corresponding to two genes of alpha 1-acid glycoprotein and characterization of two alleles of AGP-1 in the mouse.

ORM1 ORM2

3.39e-05220322475311
Pubmed

NLRP12 Promotes Mouse Neutrophil Differentiation through Regulation of Non-canonical NF-κB and MAPKERK1/2 Signaling.

NLRP12 MAP3K14

3.39e-052203229483833
Pubmed

Mitochondrial targeting adaptation of the hominoid-specific glutamate dehydrogenase driven by positive Darwinian selection.

GLUD1 GLUD2

3.39e-052203218688271
Pubmed

The complex regulation of human glud1 and glud2 glutamate dehydrogenases and its implications in nerve tissue biology.

GLUD1 GLUD2

3.39e-052203222658952
Pubmed

A synthetic retinoic acid receptor agonist Am80 ameliorates renal fibrosis via inducing the production of alpha-1-acid glycoprotein.

ORM1 ORM2

3.39e-052203232651445
Pubmed

Regulation of MET receptor signaling by SOCS1 and its implications for hepatocellular carcinoma.

MET SOCS1

3.39e-052203223944359
Pubmed

Isoform differentiation of intact AGP from human serum by capillary electrophoresis-mass spectrometry.

ORM1 ORM2

3.39e-052203220617306
Pubmed

Increases in anterograde axoplasmic transport in neurons of the hyper-glutamatergic, glutamate dehydrogenase 1 (Glud1) transgenic mouse: Effects of glutamate receptors on transport.

GLUD1 GLUD2

3.39e-052203238124277
Pubmed

Deletion of glutamate dehydrogenase in beta-cells abolishes part of the insulin secretory response not required for glucose homeostasis.

GLUD1 GLUD2

3.39e-052203219015267
Pubmed

alpha 1-Acid glycoprotein binds human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein via N-linked glycans.

ORM1 ORM2

3.39e-05220327795416
Pubmed

Human GLUD1 and GLUD2 glutamate dehydrogenase localize to mitochondria and endoplasmic reticulum.

GLUD1 GLUD2

3.39e-052203219448744
Pubmed

Investigation of genetic variants of alpha-1 acid glycoprotein by ultra-performance liquid chromatography-mass spectrometry.

ORM1 ORM2

3.39e-052203219018521
Pubmed

Single amino acid substitution (G456A) in the vicinity of the GTP binding domain of human housekeeping glutamate dehydrogenase markedly attenuates GTP inhibition and abolishes the cooperative behavior of the enzyme.

GLUD1 GLUD2

3.39e-052203211950837
Pubmed

FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.

ABCF1 BEND4 ME1 DDB1 KMT2C SARS1 AP3D1 ANK1 SLC4A1AP ZNF540 RBM34 KDM4B

3.98e-054972031236774506
Pubmed

Genome-wide detection of allele specific copy number variation associated with insulin resistance in African Americans from the HyperGEN study.

KCNU1 ATP10A CSMD1

4.15e-0512203321901158
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

CHAF1B ABCF1 SMC1A DLGAP5 INTS3 PRDM2 EFTUD2 TLK1 ZNF644 TLK2 ZNF768 SLC4A1AP ARFGAP1 PROSER2 KDM4B

5.51e-057742031515302935
Pubmed

Construction of a multi-functional cDNA library specific for mouse pancreatic islets and its application to microarray.

SUSD6 PFKL FARP2 SARS1 TXNDC5 PTPRM ZNF101 FRMD4A FICD KDM4B

7.16e-053712031015747579
Pubmed

Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.

SOCS6 PLEKHH1 KMT2C FDX2 TLK2 SEMA4F DNAH2 TEX28

7.31e-05233203837704626
InteractionLTBP2 interactions

ZNF444 ZNF696 ZNF358 ZNF607 E4F1 ZNF101 ZNF251 ZNF768 ZNF749 ZNF324B ZNF646

7.44e-108519911int:LTBP2
InteractionEFEMP1 interactions

ZNF444 ZNF696 SOCS6 TXNDC5 ZNF358 E4F1 ZNF768 DDIAS ZNF646

3.72e-061231999int:EFEMP1
CytobandEnsembl 112 genes in cytogenetic band chr19q13

NLRP12 ZNF444 ZNF154 RDH13 ZNF225 ZNF829 SPRED3 ZNF836 ZNF345 NPAS1 ZNF573 ZNF607 MEGF8 ZNF540 ZSCAN5C ZNF749 ZNF565 ZNF324B

6.85e-06119220318chr19q13
Cytoband19q13.12

ZNF829 ZNF345 ZNF573 ZNF540 ZNF565

1.77e-0572203519q13.12
Cytoband10q23.3

GLUD1 TNKS2

4.03e-047203210q23.3
Cytoband19q13.43

ZNF444 ZSCAN5C ZNF749 ZNF324B

6.20e-0487203419q13.43
GeneFamilyZinc fingers C2H2-type|ZF class homeoboxes and pseudogenes

ZNF133 ZNF444 ZNF140 ZNF672 ZNF154 ZNF696 ZNF225 ZNF829 ZNF836 WIZ ZNF358 ZNF345 ZNF311 ZNF573 ZNF607 E4F1 ZNF101 ZNF251 ZNF768 ZBTB46 ZNF517 ZNF540 ZSCAN5C ZNF749 ZFP92 ZSCAN16 ZNF565 ZNF324B ZNF333 ZNF700 ZNF646

2.99e-157181393128
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

NLRP12 KCNU1 ANK1 DNAH2 SLC34A1 LRP2 ARHGEF4 CSMD1

9.88e-0716720283edb0570e583bb527165bcd8a4c25a042054043b
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADGRV1 PKHD1 ONECUT3 ANK1 HMCN1 LRP2 CSMD1 ST18

2.04e-0618420282cbed6462fea2622871bb7e49b0df3d984239281
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADGRV1 PKHD1 ONECUT3 ANK1 HMCN1 LRP2 CSMD1 ST18

2.04e-061842028ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADGRV1 PKHD1 ONECUT3 ANK1 HMCN1 LRP2 CSMD1 ST18

2.04e-0618420282b19a8c5f823e00812908b23e66bb4e563278aff
ToppCellLPS_IL1RA-Endothelial-Endothelial-Artery|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

ADGRG1 MET PTPRG PTPRM GLUD1 MMP16 HMCN1 CSMD1

3.79e-062002028ac9ead34afa14067171833f5c277eaf06db7b02e
ToppCellP28-Epithelial-epithelial_progenitor_cell-epi_progenitor|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

CHAF1B ME1 MET GGACT EGFL6 LRP2 ARHGEF4

7.03e-061552027be575a0096415705dba425002247289ff8f89474
ToppCell5'-Adult-SmallIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

GDPD1 FARP2 KMT2C TRPM5 PGGHG CSMD1 ST18

1.19e-0516820278072d0496b7b730c4601009eaa69ec5366d26d73
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

SLC10A4 MET PTPRM GRIN3A NPNT NPAS1 EGFL6

1.79e-051792027c7afbd10072d36a35cd20ae73670d76b9cefd22d
ToppCelldroplet-Lung-nan-18m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DLGAP5 CHEK1 SOWAHC ME1 TLK1 FAM83D BEST1

1.86e-05180202743fd5c498a87bb078d101298b472656f3294686a
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

SLC10A4 METAP1D PTPRM GRIN3A NPAS1 ANK1 EGFL6

1.86e-051802027b6efdb4d319ef6f87f559acd974e5a71b06a2322
ToppCellStriatum-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4-POLYDENDROCYTE_(Rostral-�migratory_stream-�(RMS)_(Notum))|Striatum / BrainAtlas - Mouse McCarroll V32

CHAF1B TNFSF9 RADX AOC2 PCSK4

2.04e-0573202550a8164d967f2706344adcdc1562dc08c9f16c8f
ToppCelldroplet-Lung-immune-endo-depleted-3m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADGRG1 ME1 MET SPDEF SEMA4F EGFL6 LRP2

2.63e-051902027aaf5f1c1ff7b1454f4e5dacfeb48e1c3627e3372
ToppCelldroplet-Lung-immune-endo-depleted-3m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADGRG1 ME1 MET SPDEF SEMA4F EGFL6 LRP2

2.63e-051902027a20123d5c6cb8c2f0dfd99bbfdb571a73c36234d
ToppCellChildren_(3_yrs)-Endothelial-endothelial_cell_of_artery|Children_(3_yrs) / Lineage, Cell type, age group and donor

GIPC2 PTPRG PTPRM MMP16 PPM1D HMCN1 CSMD1

2.63e-051902027f6c38d197fd9d69a4f97cb2e72cd4747984c1a86
ToppCellPCW_05-06-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

ADGRG1 ADGRV1 MET PKHD1 NPNT LLGL2 LRP2

2.72e-05191202705731ece7867659c662f952812805f947032fe10
ToppCelldroplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DLGAP5 ADGRG1 PTPRG FSCN2 FAM83D DNAH2

2.98e-051312026419a0a83b38eaea890d065c3f252ef83c2d37b5b
ToppCellPBMC-Mild-cDC_4|Mild / Compartment, Disease Groups and Clusters

ZNF154 ADGRG1 PLEKHH1 GUCY2D ZNF749 MAPKBP1

3.25e-051332026e53fbd69775a4bff61de82557342f7ac80915c4d
ToppCell(5)_Dendritic_cell-(54)_pDC|(5)_Dendritic_cell / shred on Cell_type and subtype

IRF8 CYB561A3 ZNF251 SUSD1 ZNF540 SLITRK5 SNTA1

3.42e-051982027fc6c6b60dddd7f2f997af0f87fae33f1c23f34a8
ToppCellParenchymal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_plasmacytoid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

AIFM3 IRF8 ZNF101 ARFGAP1 ST18 IL27 ZNF646

3.42e-051982027c64238379798ae6b292cc1914d60548c88e652de
ToppCellBronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ADGRV1 MET PTPRM NPNT LLGL2 LRP2 FAM20A

3.53e-051992027725610310e5c5fd7120c0be9acb55bf152026ddd
Drugmethyl benzoquate

GLUD1 GLUD2 CYB561A3

2.78e-0642033CID000026383
Diseasefascioliasis (biomarker_via_orthology)

GLUD1 GLUD2

1.27e-0431932DOID:885 (biomarker_via_orthology)
DiseaseNeurodevelopmental Disorders

SMC1A KMT2C PPM1D MED13L CASK

3.71e-04931935C1535926
Diseaseprostate carcinoma (is_marker_for)

MET BMP4 SARS1

4.43e-04231933DOID:10286 (is_marker_for)
Diseaselaryngeal carcinoma (is_marker_for)

KMT2C SOCS1

6.27e-0461932DOID:2600 (is_marker_for)
Diseaselow density lipoprotein cholesterol measurement, multiple sclerosis

FCRL3 MAP3K14

6.27e-0461932EFO_0004611, MONDO_0005301
Diseasechildhood absence epilepsy (biomarker_via_orthology)

GLUD1 GLUD2

6.27e-0461932DOID:1825 (biomarker_via_orthology)
Diseaseserine protease inhibitor Kazal-type 2 measurement

ORM1 ORM2

6.27e-0461932EFO_0802054
Diseaseblood chromium measurement

PTPRM ARHGEF4 HS6ST3

6.41e-04261933EFO_0007579
Diseasecutaneous melanoma, hair color

GIPC2 ADGRV1 MED13L ATP10A

7.36e-04621934EFO_0000389, EFO_0003924
Diseaseblood urea nitrogen measurement

GIPC2 ADGRV1 BMP4 CLCNKB PKHD1 ZNF607 PPM1D SUSD1 SLC34A1 LRP2

8.36e-0445219310EFO_0004741
Diseasearachidonate 15-lipoxygenase B measurement

NLRP12 GUCY2D

8.75e-0471932EFO_0801391
Diseaseautosomal dominant polycystic kidney disease (biomarker_via_orthology)

SLC34A1 LRP2

8.75e-0471932DOID:898 (biomarker_via_orthology)
Diseasehematocrit

SLC10A4 ADGRV1 PFKL ZNF829 MET CLCNKB PKHD1 NYAP1 AP3D1 ZNF345 TRMT112 DNAH2 FRMD4A SUSD1 SLC34A1 LRP2

1.05e-03101119316EFO_0004348
Diseaseprotein-tyrosine sulfotransferase 2 measurement

NLRP12 PAFAH1B2

1.16e-0381932EFO_0801971
Diseasemelanoma

GIPC2 ADGRV1 FARP2 ZBTB46 SNTA1

1.46e-031261935EFO_0000756
Diseaseresponse to lamotrigine

GRIN3A CSMD1

1.49e-0391932EFO_0007661
Diseaseresponse to ondansetron, QT interval

MPDZ ARHGEF4

2.25e-03111932EFO_0004682, EFO_0020997
Diseasecoagulation factor XA measurement

ORM1 ORM2

2.25e-03111932EFO_0020266
DiseaseMouth Diseases

CHAF1B GSS

2.69e-03121932C0026636
Diseasephysical activity

AEBP2 PKHD1 GRIN3A CSMD1

2.70e-03881934EFO_0003940
Diseasesquamous cell carcinoma, multiple keratinocyte carcinoma susceptibility measurement, basal cell carcinoma

PKHD1 CSMD1

3.17e-03131932EFO_0000707, EFO_0004193, EFO_0007932
Diseasecoagulation factor X measurement

ORM1 ORM2

3.17e-03131932EFO_0020265
DiseaseLeber congenital amaurosis (implicated_via_orthology)

RDH13 GUCY2D

3.17e-03131932DOID:14791 (implicated_via_orthology)
DiseaseCongenital pontocerebellar hypoplasia

RARS2 CASK

3.17e-03131932C0266468
DiseaseHereditary Diffuse Gastric Cancer

TNFSF9 WDR46 DDB1 MET KMT2C PTPRG ARFGAP2

3.28e-032931937C1708349
DiseaseStomach Neoplasms

TNFSF9 WDR46 DDB1 MET KMT2C PTPRG ARFGAP2

3.53e-032971937C0038356
Diseasepneumonia

GIPC2 EXD3 IL27

3.62e-03471933EFO_0003106
Diseaseend stage renal disease (biomarker_via_orthology)

ACAT1 SLC34A1 LRP2

3.62e-03471933DOID:783 (biomarker_via_orthology)
DiseaseMalignant neoplasm of stomach

TNFSF9 WDR46 DDB1 MET KMT2C PTPRG ARFGAP2

3.73e-033001937C0024623
DiseaseOpioid use measurement

BEND4 AEBP2

4.23e-03151932EFO_0009937
Diseasehepatic encephalopathy (biomarker_via_orthology)

GLUD1 GLUD2

4.23e-03151932DOID:13413 (biomarker_via_orthology)
DiseaseAdenoid Cystic Carcinoma

SMC1A FGF16 KMT2C TLK1

4.27e-031001934C0010606
Diseasegalectin-3 measurement

NLRP12 DLGAP5

4.81e-03161932EFO_0008137
Diseasemonoclonal gammopathy

FRMD4A CSMD1 HS6ST3

5.08e-03531933EFO_0000203
Diseaseautosomal dominant intellectual developmental disorder (is_implicated_in)

TLK2 KDM4B

5.43e-03171932DOID:0060307 (is_implicated_in)
DiseaseMalignant mesothelioma

MET SEMA4F COPG1 ULK2

5.79e-031091934C0345967
Diseasepeptide measurement

TLK1 MMP16 ZNF573 CSMD1

5.79e-031091934EFO_0010520
Diseaserefractive error

METAP1D BMP4 GGACT NYAP1 FER1L4 GUCY2D ST18

5.83e-033261937MONDO_0004892
Diseasealcoholic hepatitis (biomarker_via_orthology)

ABCB11 SOCS1

6.08e-03181932DOID:12351 (biomarker_via_orthology)
Diseasesexual dimorphism measurement

GIPC2 CDC20B RAD54L2 FARP2 PTPRG SPDEF AP3D1 NPAS1 GSS ZBTB46 FER1L4 PAFAH1B2 MAPKBP1 SNTA1 IL27

6.31e-03110619315EFO_0021796

Protein segments in the cluster

PeptideGeneStartEntry
GALHENRHGSAVQIR

PTPRG

36

P23470
LGRFGLESHAHTIQI

ABCF1

726

Q8NE71
HIRSIHVDGQRGGVF

AEBP2

281

Q6ZN18
QHGAGVRHAGVQTSR

CDR2L

376

Q86X02
ARHHGLLASARQPGV

EGFL6

26

Q8IUX8
RAAVEVLRGHGLHSV

ANAPC2

56

Q9UJX6
NGHRHGGDFGIRSTV

CSMD1

881

Q96PZ7
AGVVYLHGIGITHRD

CHEK1

116

O14757
QGNGTARHFHTEERL

AIFM3

41

Q96NN9
SLVSGHQRGQARITH

ANK1

1671

P16157
THRLHLNRFSVSGTG

GRM3

836

Q14832
GGREHVAHLLFLRDT

ORM2

111

P19652
VGHARQGRAVGTFLH

BEND4

491

Q6ZU67
ANITVRRSGGHFGRL

ADGRV1

2371

Q8WXG9
NAFRLHRGATGDSHL

ARHGEF4

571

Q9NR80
FQHGTAGRIHRLASA

CHAF1B

21

Q13112
IIGFEHGTAVERGTH

ABCB11

626

O95342
SGRHRGLGVHLSFVR

ARFGAP1

46

Q8N6T3
RLVFHAQLAHGSATG

GIPC2

41

Q8TF65
HAGIIGRFLGLQSHD

BEST1

386

O76090
GVHRSLGVHLSFIRS

ARFGAP2

51

Q8N6H7
TFHTRIGGDLTHGII

APRG1

31

Q8IVJ8
RHSGIGHGQASSAVR

FLG

2666

P20930
HSFNSFRLRVGINHG

ADCY7

981

P51828
LHSLLEGFVQRRGHT

RAD54L2

551

Q9Y4B4
FPRARLAAIGSTHGH

C1orf147

76

Q96MC9
HAGGRRSGQSHELLR

BMP4

41

P12644
RGSIGSHQSVRVVHR

ATP10A

481

O60312
TRLEGTRHGHLIAAQ

AP3D1

426

O14617
LVTGAGRGHAGRIIH

RAB3GAP1

881

Q15042
GRGHAGRIIHKLFVN

RAB3GAP1

886

Q15042
GQVASSLFRGEHHSR

RBM34

36

P42696
EHHSRGGTGRLASLF

RBM34

46

P42696
AFGTIAIQLAHHRGA

CRYZL1

156

O95825
GHVRQGVFSSLNHIV

INTS3

451

Q68E01
HVTGRLRAHALGLVA

NPAS1

271

Q99742
GCTVDVNHFGAHVRR

SLC10A4

121

Q96EP9
RSLGHFEVTILGLNH

RADX

746

Q6NSI4
LHRAVGHFELRKNGT

ASB8

211

Q9H765
RVGERVLGTVHTHAF

AOC2

506

O75106
GAHGVGRRHIKNTLI

CASK

746

O14936
HTFRVGSLIFHTIGQ

KMT2C

4546

Q8NEZ4
RGLFITIHDRGHIAS

ME1

121

P48163
GVHLLVRRGSHRIFS

METAP1D

6

Q6UB28
GVGSHFQHSRSQGER

MED13L

2066

Q71F56
GTSHGFGLFDHQQRR

LLGL2

606

Q6P1M3
VGSFLHRVGARVPHA

MFHAS1

516

Q9Y4C4
RHKVTGLHSGTLQVF

NPNT

486

Q6UXI9
GLHSGTLQVFVRKHG

NPNT

491

Q6UXI9
RSSHVGSGPRVVAHF

NUDT16

96

Q96DE0
GRFVLKITDHGHGRL

GUCY2D

676

Q02846
VHRGGHFDTPVQFLR

HECA

331

Q9UBI9
RLGSSLRHGIGHIEA

KCNK4

141

Q9NYG8
LHTIVRGFIHSAVGG

SLC43A2

456

Q8N370
HVRQQHLRAGGAAAS

FAM43B

216

Q6ZT52
AGRFRTTQVLVGHHI

FICD

306

Q9BVA6
IERRAFGHTVLVGSH

FER1L4

1011

A9Z1Z3
AFVHRCGRTARIGHG

DDX55

351

Q8NHQ9
HVGVGHSGNITRIRI

CFAP52

581

Q8N1V2
SGRVGDNVLHLAQRH

FDX2

86

Q6P4F2
RFFNHTRLVTAGPGH

PCSK4

626

Q6UW60
GTRITIHGNDLHVGS

PLXND1

996

Q9Y4D7
FGHLERGVLLHSSRQ

IRF8

271

Q02556
VENGNGRRHASVLLH

IL1RAPL1

336

Q9NZN1
AAVRSAVRTGISHGH

PFKL

416

P17858
VSLTHHVGLRRAGVL

PDE3B

496

Q13370
PISGFHQTRIHGINR

DDIAS

776

Q8IXT1
RRTLFTENHLGLHSG

FAM83D

551

Q9H4H8
HGGHRPSTARFSVRV

MEGF8

406

Q7Z7M0
HKSGGHAVQLLRAVS

KDM4B

906

O94953
NHRVLRDGAHGSAAF

GGACT

16

Q9BVM4
QRFLSKHISHRGGAG

GDPD1

36

Q8N9F7
GTIARSHVRSLHFQG

KCNU1

71

A8MYU2
HSTFDGLDRRRLGHI

LRP2

896

P98164
LGTRVFHDTLHVSGV

PGGHG

31

Q32M88
GHGGREAAQFAREHL

PPM1D

106

O15297
LAHGTTTLAFRFRHG

PSMB11

46

A5LHX3
RAHLAADRHGGSVQV

CSNK1G3

381

Q9Y6M4
LHIQKTGGTTFGRHL

HS6ST3

151

Q8IZP7
GVARTELGRHTGIHG

RDH13

231

Q8NBN7
GFLHIQSAHVTDTGR

HMCN1

3766

Q96RW7
HREGTFNHTLRLIGE

KIR2DS5

61

Q14953
HHPSQGFRFGTVRES

GRIN3A

786

Q8TCU5
HITRLVVASFNIHGG

SLC34A1

246

Q06495
RHTFLQAGLSVGGRR

PFN3

56

P60673
SVTRRTFGHSGIAVH

FRMD4A

281

Q9P2Q2
GRSHNRGSRTGYVHI

KLHL22

551

Q53GT1
HGRISATGRGVFHGI

GLUD1

266

P00367
ARSVGRSAHIQASGH

CENPT

66

Q96BT3
VRGQAHRFAESHLPG

IL27

61

Q8NEV9
RHQEHARHISFGGNL

DLGAP5

821

Q15398
LLFLVQGAHGRGHRE

ADGRG1

16

Q9Y653
EIHQAGGGIHFTVER

AMDHD1

111

Q96NU7
GLGAQHSHGVSLRVT

FCRL3

456

Q96P31
FQGNTIHLRGTHRDS

HEPHL1

661

Q6MZM0
RTLGLFQHHDAITGT

MAN2A2

561

P49641
SGDGVQFTRTHHVVR

MAPKBP1

601

O60336
GGQEHFAHLLILRDT

ORM1

111

P02763
RSGGFFGHRGRVLHL

CDC20B

481

Q86Y33
GHRANRTVPGAHSRL

GPR156

621

Q8NFN8
RTVPGAHSRLHVQNG

GPR156

626

Q8NFN8
DAVTVHSTHGGFLIR

CRIPAK

416

Q8N1N5
GILSGHVHDRGQVFV

GLB1L2

441

Q8IW92
HTLLLAGVFRGGHDI

COPG1

826

Q9Y678
VGLVAVFTFHNHGRT

CYB561A3

96

Q8NBI2
GRGFAEHGTLNRHLR

E4F1

581

Q66K89
SFGGLASRTPAVHRH

GSS

151

P48637
RGVRSSLEGHGQHRA

FARP2

891

O94887
GARTQHFRGHTGAVF

FBXW2

216

Q9UKT8
FHKNLHTLRAVRGGI

DNAH2

431

Q9P225
SLRIIRNGIGIHEHA

DDB1

386

Q16531
HGRISATGRGVFHGI

GLUD2

266

P49448
VTIQGGAHHLDLRAS

DPP7

436

Q9UHL4
DLSEHRFLLHGVGNI

PRDM2

1176

Q13029
LHALNFGIGGDTTRH

PAFAH1B2

66

P68402
GVHEIREIRQFHFTG

PTPRM

1046

P28827
THQLRLGRGSFGEVH

MAP3K14

401

Q99558
GHARSAAAQHRGLVA

ONECUT3

26

O60422
VRSQGAEGLLARIHH

NYAP1

681

Q6ZVC0
LRGLDGFVCHHRGSN

FSCN2

386

O14926
LIVHFNEVIGRGHFG

MET

1076

P08581
TGRTHQIRVHLQFLG

RPUSD2

366

Q8IZ73
GSHGRDTRGIFRVHQ

SARS1

306

P49591
HVGHLRSTIIGNFIA

RARS2

141

Q5T160
VTSGFSRIGHIAHLN

TRMT5

196

Q32P41
FALRTGTRHGVDTHL

SNTA1

366

Q13424
IDLNSTHGTFLGHIR

PPP1R8

86

Q12972
GTEDGHLHRAVRIGA

SEMA4F

456

O95754
RRAQVLATIHGHAGA

PROSER2

281

Q86WR7
LIHLDNARGFGRHSH

FAM20A

426

Q96MK3
FPNGTVHGTRHDHSR

FGF16

76

O43320
FETHGTARVAQGHLL

MRGPRG-AS1

36

Q2M3A8
GARIVGHLTHALKQG

ACAT1

391

P24752
VIDGIRTGQHRSLFH

TUBAL3

81

A6NHL2
LANHVRGHLNRVGVS

WIZ

716

O95785
LHGNVVAGSERLGFH

PKHD1

3091

P08F94
VAGSERLGFHIRGHK

PKHD1

3096

P08F94
GGRALHAELVQHFRG

SOWAHC

26

Q53LP3
HAELVQHFRGALGGE

SOWAHC

31

Q53LP3
LKSFHHSRRDQGVSG

SUSD6

146

Q92537
IRVHFQAGRFHLDGS

SOCS1

126

O15524
VHDVRLNGSAAGHVL

TENT5C

66

Q5VWP2
GLGHVNNVFVTHRSL

ST18

876

O60284
QDRLRLGHFTTVRHG

TLK2

291

Q86UE8
LGRNIGSHRVRVEHF

CLCNKB

536

P51801
HAADRGERGHFGVQI

LINC02915

151

Q8N8G6
DRLRLGHFTTVRHGA

TLK1

296

Q9UKI8
FRHLADHGQLSGIQR

MRPS14

111

O60783
GRSGLSQHRRVHSGE

ZFP92

331

A6NM28
AFRSASQLRVHGGTH

ZNF700

426

Q9H0M5
SRRGQFTEHQKIHTG

ZNF540

561

Q8NDQ6
HQRIHGRAAASAQGA

ZNF444

296

Q8N0Y2
GSQLTVHRRIHTGAR

ZNF565

331

Q8N9K5
GKGFIHSSEVTRHQR

ZNF565

381

Q8N9K5
GDFHVINGVLRTAHS

CSE1L

141

P55060
FHVRATLPHFRGGET

nan

86

Q6ZSR3
SFTLGRHQRVHTGER

ZNF749

366

O43361
SQGGHLRIHQRVHTG

ZNF573

256

Q86YE8
GLARHVGQAVRDHSL

TRPM5

111

Q9NZQ8
GISLEATVGHHFIRS

MPDZ

566

O75970
FSTGRRLDFVHHSGV

MMP16

6

P51512
ETGAFHGLRGLRRLH

SLITRK5

121

O94991
HNLLSSHVRGVGSRG

TRMT112

6

Q9UI30
FQVAARLGHHRGLLE

THEM5

6

Q8N1Q8
FRQRSPLGGDVLHAH

SPDEF

191

O95238
GGARQGHYVIHGERL

SPRED3

41

Q2MJR0
RHAILVGNHSSRLGG

SUSD1

246

Q6UWL2
AFRSGAGLRSHARIH

ZNF672

171

Q499Z4
GFGQRSDLVVHQRIH

ZNF672

291

Q499Z4
SRHGLQHEGIFRVSG

SRGAP2

516

O75044
VYGRLSRHQSIHTGE

ZNF607

236

Q96SK3
GKAFSVHGRLTRHQG

ZNF607

371

Q96SK3
RGSVHFGLVRLIHGE

UBE2O

71

Q9C0C9
GRGSTLIQHQRIHTG

ZNF768

271

Q9H5H4
RALSGFFRHQRLHTG

ZNF696

331

Q9H7X3
GSLVNHRRTHETGLF

ZNF646

61

O15015
LHDGIQRVLFGHGLS

NDST2

271

P52849
RRIAFGGHQRHKTVA

SMC1A

626

Q14683
GGHQRHKTVALDGTL

SMC1A

631

Q14683
PLLTQRGSGEARHHF

TTLL3

556

Q9Y4R7
TGRHLAFGGRRGHVA

WDR46

206

O15213
QVGHGHFGRVVNIET

PLEKHH1

336

Q9ULM0
LSAGQRLGVHLHTEA

TNFSF9

206

P41273
FGHAEVVNLLLRHGA

TNKS2

101

Q9H2K2
AFGSRSDLIRHEGIH

ZNF829

416

Q3KNS6
RFTLNEHGRIHSGER

ZNF517

301

Q6ZMY9
GRAFGQSSHLIVHVR

ZNF333

596

Q96JL9
GLSRHVRVHSGETTF

ZNF225

386

Q9UK10
ECGRGFSHQAGLIRH

ZNF133

526

P52736
TFETGVGLSNHVRGH

ZNF644

971

Q9H582
GHGAFAVVFRGRHRQ

ULK2

16

Q8IYT8
AGLTGFHVVLVARGR

ZDHHC5

201

Q9C0B5
GFGSLAGSVHVRIRR

SLC30A6

291

Q6NXT4
GRAFGFNSHLTEHVR

ZNF251

411

Q9BRH9
LHERTHLAGRSQCFG

ZNF101

411

Q8IZC7
FSGRTGLIQHQRIHT

ZSCAN16

301

Q9H4T2
GRRFSLVLHQRTHTG

ZNF140

171

P52738
HSGGRDLDSLHRFVL

TXNDC5

411

Q8NBS9
HVGPRLRGETAFAFH

SLX1A

96

Q9BQ83
QRSALLQHRGVHTGE

ZNF154

256

Q13106
RSALLQHRGVHTGER

ZNF154

341

Q13106
GGLAHNLQDSVRHRI

TEX28

41

O15482
SFGSGLIRHQIIHSG

ZNF345

156

Q14585
HAFGRVLSGTIHAGQ

EFTUD2

491

Q15029
RIGLQFHQRTHTGER

ZSCAN5C

396

A6NGD5
GKTLHTRIEHSNGRF

SOCS6

426

O14544
GTRSQVEPLFTHRGH

WDR73

316

Q6P4I2
VLGVFNHVHFGQRHR

TCIRG1

551

Q13488
AASVGIRHGSRRHGV

ZBTB46

486

Q86UZ6
GKVFSQTSHLVGHRR

ZNF836

476

Q6ZNA1
HTRGVYHFSIQGRTV

TMEM249

116

Q2WGJ8
SFRQGSALIGHKRVH

ZNF311

591

Q5JNZ3
GATLAQHRGIHTGAR

ZNF358

191

Q9NW07
GFAKGAVLLSHRRIH

ZNF324B

461

Q6AW86
LLDTGRGHARTVGHQ

NLRP12

176

P59046
LHHEGRFREAATLGA

EXD3

146

Q8N9H8
RVHVGHVVRFGGSTR

SLC4A1AP

256

Q9BWU0